Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)
What is the purpose of this trial?
This study will evaluate the efficacy of ranolazine as compared with placebo when used as part of standard medical therapy in chronic angina subjects with incomplete revascularization post-PCI on the composite of ischemia-driven revascularization or ischemia-driven hospitalization without revascularization.
- 18 Years and older
- Gilead Sciences
- October 2011
- Last Updated:
- February 22, 2013
- Study HIC#:
Clinicaltrials.gov ID: NCT01442038